In a patient with a history of hypothyroidism now on levothyroxine, could iatrogenic hyperthyroidism from over‑replacement be causing new anxiety, insomnia, and suicidal ideation, and what is the appropriate evaluation and management?

Iatrogenic Hyperthyroidism Can Absolutely Cause Severe Psychiatric Symptoms Including Anxiety, Insomnia, and Suicidal Ideation

Yes, levothyroxine over-replacement causing iatrogenic hyperthyroidism is a well-established cause of severe psychiatric symptoms including anxiety, broken sleep, and suicidal ideation—this patient's symptoms should be immediately evaluated as a potential thyroid emergency rather than dismissed as primary psychiatric illness. 1, 2, 3

Immediate Clinical Recognition

The FDA explicitly lists nervousness, irritability, and insomnia as adverse reactions of levothyroxine overdosage, which represents therapeutic-induced hyperthyroidism 3. More critically:

• Hyperthyroidism precipitates anxiety through direct thyroid hormone effects on brain neurotransmitter systems and widespread activation of peripheral adrenergic receptors, creating both central nervous system dysregulation and somatic symptoms that mimic and trigger severe anxiety states 1

• Thyroid hormone receptors are widely expressed throughout the limbic system, directly modulating mood regulation centers, which explains why psychiatric symptoms can be the predominant—or even sole—manifestation of thyroid dysfunction 4, 1

• The central thyroid system cross-communicates with noradrenergic and serotonergic pathways, disrupting the neurochemical balance essential for emotional stability 1

Severity and Psychiatric Manifestations

The psychiatric symptoms from iatrogenic hyperthyroidism can be severe enough to include frank psychosis, mania, and suicidal ideation—not just mild anxiety. 5, 6

• A documented case report describes acute mania developing within 24 hours of full-replacement levothyroxine dosing in a hypothyroid patient, requiring sedatives and neuroleptics 5

• Hyperthyroidism can present with depression and psychosis, with psychotic symptoms typically manifesting as affective psychosis 6

• Approximately one-quarter of patients receiving levothyroxine are inadvertently maintained on doses high enough to make TSH levels undetectable, putting them at risk for these severe psychiatric manifestations 2

Critical Evaluation Steps

Check TSH and free T4 immediately—suppressed (undetectable) TSH with elevated free T4 confirms iatrogenic hyperthyroidism as the cause of psychiatric symptoms. 2, 3

The American College of Physicians emphasizes that monitoring both psychiatric symptoms and thyroid parameters together is crucial, as mood symptoms may reflect subtle HPT axis dysfunction even when baseline thyroid levels appear normal 2. However, in this clinical scenario with severe symptoms, you're looking for overt over-replacement.

Key laboratory findings indicating over-replacement:

• Suppressed/undetectable TSH (most sensitive indicator) 2, 3
• Elevated free T4 and/or free T3 3
• Correlation of symptom onset with levothyroxine dose escalation or initiation

Immediate Management Algorithm

Step 1: Reduce or Hold Levothyroxine

Reduce the levothyroxine dose or discontinue temporarily if signs or symptoms of overdosage occur 3. The FDA explicitly recommends this approach for overdosage symptoms, which include the psychiatric manifestations this patient is experiencing 3.

• Administer the minimum dose of levothyroxine that achieves the desired clinical and biochemical response to minimize the risk of anxiety and other adverse effects 2
• Peak therapeutic effect may not be attained for 4 to 6 weeks after dose adjustment, so symptom resolution will not be immediate 3

Step 2: Symptomatic Management

While awaiting thyroid normalization:

• Initiate appropriate supportive treatment as dictated by the patient's medical status 3
• Consider beta-blockers (propranolol) to address peripheral adrenergic symptoms and provide some symptomatic relief 7
• Short-term anxiolytics or neuroleptics may be necessary for severe psychiatric symptoms, as documented in case reports 5

Step 3: Monitor Recovery Timeline

Normalization of thyroid function after iatrogenic hyperthyroidism is expected to produce marked reduction in anxiety symptoms, though the exact timeline and degree of recovery can vary 1

• Full resolution of mood disturbances is not guaranteed; recovery may be affected by the initial severity of hyperthyroidism (overt versus subclinical) and patient-specific factors such as body mass index, smoking status, and coexisting depressive conditions 1
• Psychiatric manifestations of thyroid dysfunction will abate with appropriate thyroid hormone adjustment, unless the disease state has been sufficiently prolonged to cause some irreversible brain damage 8

Critical Pitfalls to Avoid

The most dangerous error is attributing these symptoms solely to primary psychiatric illness and initiating psychiatric medications without first correcting the thyroid over-replacement. 2, 8

• Hypothyroidism and hyperthyroidism can both be misdiagnosed as psychiatric illness 8
• Thyroid function screening is mandated for patients presenting with depression, psychosis, or organic mental disorder 8
• Some patients may have both primary psychiatric illness and thyroid dysfunction as aggravating factors, requiring treatment of both conditions 7

Do not continue current levothyroxine dosing while treating psychiatrically—this perpetuates the underlying cause and delays recovery 2, 3.

Long-term Considerations

After acute management:

• Adequacy of therapy must be determined with periodic monitoring of TSH and/or T4 as well as clinical status 3
• The comorbidity between anxiety disorders and thyroid disorders is significant, with nearly all studies finding this association 4
• An inverse relationship exists between self-reported anxiety levels and TSH in large population samples 4